MCID: DYS021
MIFTS: 44

Dysautonomia malady

Categories: Genetic diseases, Rare diseases, Neuronal diseases, Eye diseases, Skin diseases

Aliases & Classifications for Dysautonomia

Aliases & Descriptions for Dysautonomia:

Name: Dysautonomia 51 29 52 69

Classifications:



Summaries for Dysautonomia

NINDS : 51 Dysautonomia refers to a disorder of autonomic nervous system (ANS) function that generally involves failure of the sympathetic or parasympathetic components of the ANS, but dysautonomia involving excessive or overactive ANS actions also can occur. Dysautonomia can be local, as in reflex sympathetic dystrophy, or generalized, as in pure autonomic failure. It can be acute and reversible, as in Guillain-Barre syndrome, or chronic and progressive. Several common conditions such as diabetes and alcoholism can include dysautonomia. Dysautonomia also can occur as a primary condition or in association with degenerative neurological diseases such as Parkinson's disease. Other diseases with generalized, primary dysautonomia include multiple system atrophy and familial dysautonomia. Hallmarks of generalized dysautonomia due to sympathetic failure are impotence (in men) and a fall in blood pressure during standing (orthostatic hypotension). Excessive sympathetic activity can present as hypertension or a rapid pulse rate.

MalaCards based summary : Dysautonomia is related to dysautonomia, familial and dysautonomia like disorder. An important gene associated with Dysautonomia is ACTL7B (Actin Like 7B), and among its related pathways/superpathways are Neuroscience and Neurotrophic factor-mediated Trk receptor signaling. The drugs Dopamine and Metoprolol have been mentioned in the context of this disorder. Affiliated tissues include brain, heart and spinal cord.

Wikipedia : 71 Dysautonomia is a term for a group of diseases that include postural orthostatic tachycardia syndrome... more...

Related Diseases for Dysautonomia

Diseases in the Dysautonomia family:

Dysautonomia, Familial Dysautonomia Like Disorder

Diseases related to Dysautonomia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 160)
id Related Disease Score Top Affiliating Genes
1 dysautonomia, familial 12.4
2 dysautonomia like disorder 11.9
3 motor neuropathy, peripheral, with dysautonomia 11.8
4 acute cholinergic dysautonomia 11.8
5 autonomic dysfunction 11.5
6 pure autonomic failure 11.5
7 insensitivity to pain, congenital, with anhidrosis 11.5
8 orthostatic intolerance 11.0
9 parkinson disease 1 10.9
10 stuve-wiedemann syndrome/schwartz-jampel type 2 syndrome 10.9
11 hereditary sensory neuropathy 10.8
12 neuropathy, hereditary sensory and autonomic, type vi 10.8
13 parkinson disease, late-onset 10.7
14 insomnia, fatal familial 10.7
15 autoimmune autonomic ganglionopathy 10.7
16 primary orthostatic hypotension 10.7
17 rigidity and multifocal seizure syndrome, lethal neonatal 10.7
18 postural hypotension 10.7
19 gastroduodenal crohn's disease 10.1 ELP1 NGF
20 auriculocondylar syndrome 1 10.1 NGF NTRK2
21 walker-warburg syndrome 10.1 NGF NTRK2
22 rumination disorder 10.1 DBH NGF
23 brain injury 10.1
24 neuropathy 10.1
25 fissured tongue 10.1 ELP1 NGF
26 hemopericardium 10.0 DBH NGF
27 traumatic brain injury 10.0
28 postmenopausal atrophic vaginitis 10.0 NGF NTRK2
29 cystadenoma 10.0 NGF NTRK2
30 neuronitis 10.0
31 cerebral atrophy 10.0 DBH SNCA
32 pythiosis 9.9 DBH SNCA
33 autonomic neuropathy 9.9
34 nephrogenic adenoma of the urethra 9.9 DBH SNCA
35 ovarian mucinous adenocarcinoma 9.9 NGF SNCA
36 polyneuropathy 9.8
37 multiple system atrophy 9.8
38 leprosy 9.7
39 myopathy 9.7
40 preeclampsia/eclampsia 5 9.7 DBH NGF SNCA
41 autism 19 9.7 DBH SNCA
42 syncope 9.7
43 cerebritis 9.7
44 esophagitis 9.7
45 chronic fatigue syndrome 9.7
46 chagas disease 9.7
47 long qt syndrome 5 9.6 NGF NTRK2 SNCA
48 dopamine beta-hydroxylase deficiency 9.6
49 spasticity 9.6
50 myasthenia gravis 9.6

Graphical network of the top 20 diseases related to Dysautonomia:



Diseases related to Dysautonomia

Symptoms & Phenotypes for Dysautonomia

Drugs & Therapeutics for Dysautonomia

Drugs for Dysautonomia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 480)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-61-6, 62-31-7 681
2
Metoprolol Approved, Investigational Phase 4,Phase 2,Phase 1 37350-58-6, 51384-51-1 4171
3
Acetylcholine Approved Phase 4 51-84-3 187
4
Risperidone Approved, Investigational Phase 4 106266-06-2 5073
5
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
6 Zotepine Approved Phase 4 26615-21-4
7
Zolpidem Approved Phase 4 82626-48-0 5732
8
Benzocaine Approved Phase 4 1994-09-7, 94-09-7 2337
9
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
10
Levodopa Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 59-92-7 6047
11
Zinc Approved Phase 4,Phase 2 7440-66-6 32051 23994
12
Propranolol Approved, Investigational Phase 4,Phase 1,Phase 2,Early Phase 1 525-66-6 4946
13
Midodrine Approved Phase 4,Phase 3,Phase 2,Phase 1 133163-28-7, 42794-76-3 4195
14
Fludrocortisone Approved Phase 4,Phase 1 127-31-1 31378
15
Droxidopa Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 23651-95-8 443940
16
Acetylcarnitine Approved, Investigational Phase 4 3040-38-8 1
17
Bisoprolol Approved Phase 4 66722-44-9 2405
18
Vitamin C Approved, Nutraceutical Phase 4,Phase 3,Early Phase 1 50-81-7 5785 54670067
19 tannic acid Approved, Nutraceutical Phase 4
20
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3 59-30-3 6037
21
Melatonin Approved, Nutraceutical, Vet_approved Phase 4,Phase 1,Phase 2,Early Phase 1 73-31-4 896
22 Pyridostigmine Bromide Phase 4,Phase 2,Phase 1 101-26-8
23 Analgesics Phase 4,Phase 3,Phase 2,Phase 1
24 Dopamine agonists Phase 4,Phase 1
25
Serotonin Phase 4,Phase 2,Phase 1,Early Phase 1 50-67-9 5202
26 Cholinergic Agents Phase 4,Phase 3,Phase 2,Phase 1
27 N 0437 Phase 4
28 Serotonin Agents Phase 4,Phase 2,Phase 1,Early Phase 1
29 Cholinesterase Inhibitors Phase 4,Phase 2,Phase 1
30 Adrenergic Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
31 Serotonin Antagonists Phase 4
32 GABA Agents Phase 4,Early Phase 1
33 GABA Agonists Phase 4
34 GABA-A Receptor Agonists Phase 4
35 Adrenergic Antagonists Phase 4,Phase 2,Phase 1,Early Phase 1
36 Neuromuscular Agents Phase 4
37 Adrenergic beta-1 Receptor Antagonists Phase 4,Phase 2,Phase 1
38 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
39 Adrenergic beta-Antagonists Phase 4,Phase 2,Phase 1,Early Phase 1
40 Sympatholytics Phase 4,Phase 3,Phase 2,Phase 1
41 Trace Elements Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1
42 Tranquilizing Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
43 Anesthetics Phase 4,Phase 3,Phase 2,Phase 1
44 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
45 Anesthetics, Local Phase 4,Phase 3,Phase 1
46 Dopamine Agents Phase 4,Phase 3,Phase 2,Phase 1
47 Vasoconstrictor Agents Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1
48 Dopamine Antagonists Phase 4,Phase 3,Phase 1
49 Vasodilator Agents Phase 4,Phase 2,Phase 1,Early Phase 1
50 Hypnotics and Sedatives Phase 4,Phase 1,Early Phase 1

Interventional clinical trials:

(show top 50) (show all 456)
id Name Status NCT ID Phase
1 Risperidone and Zotepine in the Treatment of Delirium Unknown status NCT00622011 Phase 4
2 Effect of Rotigotine Patch Treatment on Cardiovascular Markers in Idiopathic Restless Legs Syndrome Unknown status NCT01823770 Phase 4
3 Closed Loop Stimulation for Neuromediated Syncope (SPAIN Study) Unknown status NCT01621464 Phase 4
4 Botulinum A Toxin in Patients With Parkinson's Disease Unknown status NCT00822913 Phase 4
5 Botox for Neurogenic Detrusor Overactivity and the Prevention of Autonomic Dysreflexia Following SCI Unknown status NCT02298660 Phase 4
6 Duodenal Levodopa Infusion, Quality of Life and Autonomic Nervous System in Parkinson's Disease Completed NCT00914134 Phase 4
7 Heart Rate Variability in Fibromyalgia - Effects of Strengthening Exercises Completed NCT02004405 Phase 4
8 Propranolol to Treat Fainting Due to Sympathoadrenal Imbalance Completed NCT00060866 Phase 4
9 Sympathetic Heart Innervation in Patients With Tako-Tsubo Cardiomyopathy Completed NCT01524861 Phase 4
10 Prophylactic Administration of Vitamin C in Wrist Fractures Completed NCT00296868 Phase 4
11 Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study Completed NCT02308124 Phase 4
12 Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension Completed NCT01518946 Phase 4
13 Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension Completed NCT01515865 Phase 4
14 Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension Completed NCT00555880 Phase 4
15 A Study for Patients With Neurogenic Orthostatic Hypotension Completed NCT00046475 Phase 4
16 Clinical Trial for the Prevention of Vasovagal Syncope Completed NCT00118482 Phase 4
17 High Frequency Stimulation Trials in Patients With Precision Spinal Cord Stimulator System Completed NCT02265848 Phase 4
18 A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions Completed NCT00904202 Phase 4
19 Restore Claims Characterization Study Completed NCT00200122 Phase 4
20 Oral Melatonin Plus Zinc Supplementation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) Recruiting NCT03000777 Phase 4
21 Effects of DPP4 Inhibitor Versus SGLT2 Inhibitor Recruiting NCT03178591 Phase 4
22 Dawn Simulation and Postural Hypotension Recruiting NCT02632318 Phase 4
23 Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension Recruiting NCT02586623 Phase 4
24 Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects Recruiting NCT02123056 Phase 4
25 Assessment of Midodrine in the Prevention of Vasovagal Syncope: The Prevention of Syncope Trial IV Recruiting NCT01456481 Phase 4
26 Rotigotine Effect on Nocturnal Hypokinesia Compares to Placebo Control: A Quantitative Assessment by Wearable Sensors Active, not recruiting NCT03098368 Phase 4
27 Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS) Active, not recruiting NCT02171988 Phase 4
28 Autonomic Dysfunction and Spinal Cord Stimulation in Complex Regional Pain Syndrome Terminated NCT00780390 Phase 4
29 A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension Terminated NCT00046163 Phase 4
30 A Study Evaluating Hypotension and Autonomic Nervous System Dysfunction in Multiple Myeloma (MM) Patients Unknown status NCT01314625 Phase 3
31 Post-Exercise Hypotension in Elderly Hypertensive Men Unknown status NCT02415582 Phase 3
32 Clinical Trial on the Effectiveness of Traditional Chinese Medicinal Mixture in Parkinson Disease Unknown status NCT00629161 Phase 2, Phase 3
33 Surgical Treatment Of Complex Regional Pain Syndrome Type II (CRPS II) Unknown status NCT01392599 Phase 3
34 Acupuncture for Post-stroke Shoulder-hand Syndrome Unknown status NCT02011854 Phase 2, Phase 3
35 RCT :Thoracic Sympathetic Block for the Treatment of Complex Regional Pain Syndrome I of the Upper Limb Unknown status NCT01612364 Phase 3
36 Analysis of Photoplethysmographic Signal in Lumbar Sympathetic Block Unknown status NCT01134289 Phase 3
37 Intravenous Immunoglobulins in Complex-regional Pain Syndrome Unknown status NCT00949065 Phase 3
38 The Effects Of Bronchodilator Therapy On Respiratory And Autonomic Function In Patients With Familial Dysautonomia Completed NCT01987219 Phase 3
39 Carbidopa for the Treatment of Nausea and Vomiting in Familial Dysautonomia Completed NCT01212484 Phase 3
40 Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis Completed NCT00409175 Phase 2, Phase 3
41 The Effect of Diet on Chronic Inflammation and Related Disorders Following Spinal Cord Injury Completed NCT02099890 Phase 3
42 Evaluating the Effectiveness of Intravenous Immunoglobulin Therapy in Autoimmune Autonomic Ganglionopathy Completed NCT01522235 Phase 2, Phase 3
43 Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304) Completed NCT01132326 Phase 3
44 A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa Completed NCT00782340 Phase 3
45 Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) Completed NCT00633880 Phase 3
46 Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) Completed NCT00738062 Phase 3
47 Clinical Trial on the Effectiveness of Herbal Medicinal Mixture in Parkinson Disease Completed NCT00656253 Phase 2, Phase 3
48 Progression Rate of MSA Under EGCG Supplementation as Anti-Aggregation-Approach Completed NCT02008721 Phase 3
49 Study About Efficacy and Safety to Treat Multi-System-Atrophy Completed NCT00146809 Phase 3
50 Efficacy of Midodrine for the Prevention of Orthostatic Hypotension During Early Mobilization After Fast-track Hip Arthroplasty Completed NCT01707953 Phase 3

Search NIH Clinical Center for Dysautonomia

Genetic Tests for Dysautonomia

Genetic tests related to Dysautonomia:

id Genetic test Affiliating Genes
1 Dysautonomia 29

Anatomical Context for Dysautonomia

MalaCards organs/tissues related to Dysautonomia:

39
Brain, Heart, Spinal Cord, Testes, Skin, Colon, Bone

Publications for Dysautonomia

Articles related to Dysautonomia:

(show top 50) (show all 588)
id Title Authors Year
1
Psychiatric manifestations and dysautonomia at the onset of focal epilepsy in adults: Clinical signs indicating autoimmune origin. ( 27311973 )
2016
2
Mother-induced hypertension in familial dysautonomia. ( 26589199 )
2016
3
Poster 72 Teetering on the Edge: Rehabilitation in a Medically Complex Patient with Familial Dysautonomia (Hereditary Sensory Autonomic Neuropathy Type III): A Case Report. ( 27672840 )
2016
4
Sensory and autonomic deficits in a new humanized mouse model of familial dysautonomia. ( 26769677 )
2016
5
Cerebral autoregulation and symptoms of orthostatic hypotension in familial dysautonomia. ( 27613312 )
2016
6
Axon Transport and Neuropathy: Relevant Perspectives on the Etiopathogenesis of Familial Dysautonomia. ( 26724390 )
2016
7
Dysautonomia in prodromal I+-synucleinopathy: peripheral versus central autonomic degeneration. ( 26842960 )
2016
8
Tocotrienol Treatment in Familial Dysautonomia: Open-Label Pilot Study. ( 27129499 )
2016
9
Body weight and dysautonomia in early Parkinson's disease. ( 27357472 )
2016
10
MicroRNA screening identifies a link between NOVA1 expression and a low level of IKAP in familial dysautonomia. ( 27483351 )
2016
11
Human papilloma virus vaccination and dysautonomia: Considerations for autoantibody evaluation and HLA typing. ( 27553747 )
2016
12
Poster 257 Tizanidine Reduces Night Sweats due to Dysautonomia in Syringomyelia: A Case Report. ( 27673012 )
2016
13
Prominent dysautonomia in a patient with POEMS syndrome. ( 27165541 )
2016
14
Obstructive Sleep Disordered Breathing Is More Common than Central in Mild Familial Dysautonomia. ( 27655467 )
2016
15
Dysautonomia Differentially Influences the Effect of Affective Pain Perception on Quality of Life in Parkinson's Disease Patients. ( 27239367 )
2016
16
Twenty-four-hour blood pressure profile, orthostatic hypotension, and cardiac dysautonomia in elderly type 2 diabetic hypertensive patients. ( 27624333 )
2016
17
Familial Dysautonomia: Mechanisms and Models. ( 27561110 )
2016
18
Familial dysautonomia: History, genotype, phenotype and translational research. ( 27317387 )
2016
19
Balance training using an iPhone application in people with familial dysautonomia: three case reports. ( 25504486 )
2015
20
Canine dysautonomia in a litter of Havanese puppies. ( 26179098 )
2015
21
A patient with PMP22-related hereditary neuropathy and DBH-gene-related dysautonomia. ( 26410747 )
2015
22
Evidence of brainstem dysfunction in patients with familial dysautonomia and carriers of the IKBKAP mutation. ( 26525363 )
2015
23
Predominant Glandular Cholinergic Dysautonomia in Patients with Primary SjAPgren's Syndrome. ( 25622919 )
2015
24
Brainstem reflexes in familial dysautonomia. Reply to "Evidence of brainstem dysfunction in patients with familial dysautonomia and carriers of the IKBKAP mutation". ( 26529998 )
2015
25
Lower urinary tract dysfunction in patients with dysautonomia. ( 26530163 )
2015
26
Hypothesis: Human papillomavirus vaccination syndrome--small fiber neuropathy and dysautonomia could be its underlying pathogenesis. ( 25990003 )
2015
27
Serum catecholamines and dysautonomia in diabetic gastroparesis and liver cirrhosis. ( 26181082 )
2015
28
GABAB Encephalitis: A Fifty-Two-Year-Old Man with Seizures, Dysautonomia, and Acute Heart Failure. ( 26609456 )
2015
29
Contemporary perioperative management of adult familial dysautonomia (riley-day syndrome). ( 25909774 )
2015
30
Rectifier of aberrant mRNA splicing recovers tRNA modification in familial dysautonomia. ( 25675486 )
2015
31
Autism in the Son of a Woman with Mitochondrial Myopathy and Dysautonomia: A Case Report. ( 26634179 )
2015
32
Exploratory study comparing dysautonomia between asthmatic and non-asthmatic elite swimmers. ( 25854132 )
2015
33
Complex regional pain syndrome and dysautonomia in a 14-year-old girl responsive to therapeutic plasma exchange. ( 26011726 )
2015
34
Laughter is not always funny: breath-holding spells in familial dysautonomia. ( 25539948 )
2015
35
Increased frequency of rhabdomyolysis in familial dysautonomia. ( 26202308 )
2015
36
Vertigo with dysautonomia and serious allergy: An unusual case of juvenile MAcniA"re's disease. ( 26442804 )
2015
37
Familial Dysautonomia (FD) Human Embryonic Stem Cell Derived PNS Neurons Reveal that Synaptic Vesicular and Neuronal Transport Genes Are Directly or Indirectly Affected by IKBKAP Downregulation. ( 26437462 )
2015
38
CAPON modulates neuronal calcium handling and cardiac sympathetic neurotransmission during dysautonomia in hypertension. ( 25916729 )
2015
39
Mouse models for Familial Dysautonomia reveal underlying cellular and molecular mechanisms that cause the human disease. ( 26531342 )
2015
40
TECPR2 mutations cause a new subtype of familial dysautonomia like hereditary sensory autonomic neuropathy with intellectual disability. ( 26542466 )
2015
41
Early dysautonomia detected by heart rate variability predicts late depression in female patients following mild traumatic brain injury. ( 26560198 )
2015
42
Case report of severe Cushing's syndrome in medullary thyroid cancer complicated by functional diabetes insipidus, aortic dissection, jejunal intussusception, and paraneoplastic dysautonomia: remission with sorafenib without reduction in cortisol concentration. ( 26354794 )
2015
43
Non-randomized controlled prospective study on perioperative levels of stress and dysautonomia during dental implant surgery. ( 24981241 )
2014
44
Dysautonomia and its underlying mechanisms in the hypermobility type of Ehlers-Danlos syndrome. ( 24507822 )
2014
45
Onabotulinum toxin A for the treatment of sialorrhea in familial dysautonomia. ( 24725647 )
2014
46
A neuron autonomous role for the familial dysautonomia gene ELP1 in sympathetic and sensory target tissue innervation. ( 24917501 )
2014
47
Familial dysautonomia (FD) patients have reduced levels of the modified wobble nucleoside mcm(5)s(2)U in tRNA. ( 25450681 )
2014
48
Cardiac 123I-MIBG uptake in de novo Brazilian patients with Parkinson's disease without clinically defined dysautonomia. ( 24964109 )
2014
49
Dysautonomia in narcolepsy: evidence by questionnaire assessment. ( 25324880 )
2014
50
Hyposmia and cardiovascular dysautonomia correlatively appear in early-stage Parkinson's disease. ( 24637128 )
2014

Variations for Dysautonomia

Expression for Dysautonomia

Search GEO for disease gene expression data for Dysautonomia.

Pathways for Dysautonomia

Pathways related to Dysautonomia according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1 11.43 DBH NGF NTRK2 SNCA
2
Show member pathways
10.94 NGF NTRK2
3
Show member pathways
10 NGF NTRK2

GO Terms for Dysautonomia

Cellular components related to Dysautonomia according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 terminal bouton GO:0043195 8.62 NTRK2 SNCA

Biological processes related to Dysautonomia according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 activation of cysteine-type endopeptidase activity involved in apoptotic process GO:0006919 9.37 NGF SNCA
2 positive regulation of peptidyl-serine phosphorylation GO:0033138 9.32 NTRK2 SNCA
3 negative regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043154 9.26 NGF SNCA
4 long-term synaptic potentiation GO:0060291 9.16 NTRK2 SNCA
5 positive regulation of axonogenesis GO:0050772 8.96 NGF NTRK2
6 negative regulation of neuron apoptotic process GO:0043524 8.8 NGF NTRK2 SNCA

Molecular functions related to Dysautonomia according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 copper ion binding GO:0005507 8.62 DBH SNCA

Sources for Dysautonomia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....